NASDAQ · SOPH
SOPHiA GENETICS S.A.
$7.97+$0.10 (+1.27%)
SOPHiA GENETICS S.A.’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
Loading market information…
NASDAQ · SPOK · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Spok Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Spok Holdings, Inc.’s forward annual dividend is $1.25 per share, paid quarterly. The forward yield is 10.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Spok Holdings, Inc.’s next earnings report is currently expected on Feb 18, 2027, with estimated earnings per share of $0.17. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Spok Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Spok Holdings, Inc., operating primarily through its subsidiary, Spok, Inc., specializes in providing advanced communication solutions tailored for the healthcare sector. These crucial services span a wide international footprint, covering the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's core mission is to elevate patient outcomes by meticulously delivering critical clinical information to care teams precisely when and where it holds the most significance. Spok's service portfolio includes subscription options for both one-way and two-way messaging, alongside supplementary offerings such as voicemail functionalities and protective plans for equipment. The company also acts as a supplier of communication devices to resellers, who subsequently lease or resell these units to their own customers. A flagship offering is the Spok Care Connect platform, an integrated system engineered to streamline clinician workflows and bolster administrative compliance. In addition to its primary solutions, Spok provides professional services, regular software license updates, and comprehensive product support. It also facilitates the sale of third-party equipment. Its diverse clientele extends beyond healthcare providers to include various businesses, management personnel, field sales and service teams, members of the construction and real estate industries, manufacturing organizations, and government entities. Founded in 1986 and headquartered in Alexandria, Virginia, the company rebranded as Spok Holdings, Inc. in July 2014, having previously operated as USA Mobility, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:40 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 30, 2025 | $0.22+22.22% vs estimate | $35.69M+1.96% vs estimate |
|---|
| Q1 2025 | Apr 30, 2025 | $0.25+38.89% vs estimate | $36.29M+6.75% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | $0.18-10.0% vs estimate | $33.89M-4.53% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.97+$0.10 (+1.27%)
SOPHiA GENETICS S.A.’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
$12.85-$0.02 (-0.16%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
$23.49+$0.02 (+0.09%)
NRC Health’s quoted price sits in the upper half of its reported 52-week range, 3.73% below the high.
$9.75+$0.41 (+4.39%)
Senseonics Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.36% below the high.
$2.44+$0.02 (+0.83%)
Cerus Corporation’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
$26.24$0.00 (0.0%)
TruBridge, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.02% below the high.
$9.95-$0.04 (-0.4%)
Viemed Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.09% below the high.
$18.50$0.00 (0.0%)
Simulations Plus, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.95% below the high.
